Cassava Sciences, Inc. (SAVA) Earnings History
Net Loss26 years of earnings data (1999–2024) · Currently unprofitable on a TTM basis
Loading earnings history...
Cassava Sciences, Inc. (SAVA) Earnings Overview
As of June 23, 2026, Cassava Sciences, Inc. (SAVA) reported trailing twelve-month net income of -$106M, reflecting +77.6% year-over-year growth. The company earned $-2.20 per diluted share over the past four quarters.
Looking at the long-term picture, SAVA's historical earnings data spans multiple years. The company achieved its highest annual net income of $32M in fiscal 2013.
Cassava Sciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ACAD ($376M net income, 36.5% margin), PRAX (-$327M net income), ATNM (-$23M net income, -37652.2% margin), SAVA has comparable earnings metrics. Compare SAVA vs ACAD →
SAVA Earnings vs Peers
Earnings metrics vs comparable public companies
SAVA Historical Earnings Data (1999–2024)
26 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$24M | +75.0% | -$141M | $-0.52 | - | - |
| 2023 | -$97M | -27.5% | -$106M | $-2.32 | - | - |
| 2022 | -$76M | -135.4% | -$80M | $-1.80 | - | - |
| 2021 | -$32M | -411.3% | -$33M | $-0.81 | - | - |
| 2020 | -$6M | -36.8% | -$6M | $-0.22 | - | - |
| 2019 | -$5M | +29.4% | -$5M | $-0.24 | - | - |
| 2018 | -$7M | +45.0% | -$7M | $-0.61 | - | - |
| 2017 | -$12M | +19.8% | -$12M | $-1.82 | - | - |
| 2016 | -$15M | -5.0% | -$15M | $-2.28 | - | - |
| 2015 | -$14M | -14.2% | -$14M | $-2.16 | - | - |
| 2014 | -$12M | -139.3% | -$12M | $-1.92 | - | - |
| 2013 | $32M | +1015.4% | $31M | $4.90 | 76.7% | 76.3% |
| 2012 | -$3M | -31.9% | -$4M | $-0.54 | -31.6% | -35.8% |
| 2011 | -$3M | +78.3% | -$4M | $-0.41 | -22.8% | -30.6% |
| 2010 | -$12M | -246.8% | -$14M | $-1.97 | -71.5% | -81.5% |
| 2009 | -$3M | -122.6% | -$7M | $-0.58 | -16.9% | -32.8% |
| 2008 | $15M | -24.4% | $9M | $2.45 | 24.1% | 13.7% |
| 2007 | $20M | +228.1% | $10M | $3.08 | 30.8% | 15.4% |
| 2006 | $6M | +120.2% | $-553,000 | $0.98 | 11.5% | -1.0% |
| 2005 | -$31M | +18.8% | -$33M | $-4.90 | -603.7% | -644.0% |
| 2004 | -$38M | -74.8% | -$39M | $-7.10 | - | - |
| 2003 | -$22M | -35.7% | -$22M | $-5.13 | - | - |
| 2002 | -$16M | -11.1% | $17M | $-4.12 | -13969.3% | 14841.2% |
| 2001 | -$14M | +18.0% | -$17M | $-3.96 | - | - |
| 2000 | -$17M | -288.5% | -$20M | $-5.01 | - | - |
| 1999 | -$4M | - | -$5M | $-0.09 | - | - |
Download Data
Export SAVA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
27+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SAVA — Frequently Asked Questions
Quick answers to the most common questions about buying SAVA stock.
What is SAVA earnings per share (EPS)?
SAVA trailing twelve-month (TTM) diluted EPS is $-2.20, reflecting +77.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1999 to 2024 is available in the table on this page.
What is Cassava Sciences, Inc.'s net income?
Cassava Sciences, Inc. (SAVA) trailing twelve-month net income is $-106M as of 2024. Earnings grew +77.6% year-over-year.
Is SAVA profitable?
SAVA is not currently profitable on a TTM basis, reporting a net loss of $-106M. Net margin is N/A. Investors should monitor for a return to profitability.
What is SAVA's earnings growth rate?
SAVA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1999 to 2024.
What are SAVA's profit margins?
Cassava Sciences, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -17.2%.
Is SAVA growing earnings?
Yes, SAVA earnings are accelerating — EPS growth of +77.6% exceeds the 5-year CAGR of N/A. TTM net income reached $-106M. Earnings momentum is strengthening.
What was SAVA's best earnings year?
Cassava Sciences, Inc.'s highest annual net income on record is $32M, achieved in fiscal year 2013. Earnings history on this page spans 1999 to 2024 and includes all annual and quarterly figures.
What were SAVA's earnings last quarter?
SAVA's most recent reported quarter was Q3 2025. Net income was $-11M with diluted EPS of $-0.22. For a full breakdown of all quarters, see the quarterly earnings table on this page.